Evaluation of Teriparatide for Treatment of Osteoporosis in Four Patients with Cystic Fibrosis: A Case Series
Introduction. Bone disease is a common complication of cystic fibrosis (CF). To date, there have been no reports on the effectiveness of teriparatide, recombinant human parathyroid hormone, to treat CF-related bone disease. Case Presentation. We report on four patients with CF-related bone disease w...
Main Authors: | Oranan Siwamogsatham, Kelly Stephens, Vin Tangpricha |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2014-01-01
|
Series: | Case Reports in Endocrinology |
Online Access: | http://dx.doi.org/10.1155/2014/893589 |
Similar Items
-
Teriparatide in the management of osteoporosis
by: Donald Bodenner, et al.
Published: (2008-01-01) -
Contributors to Secondary Osteoporosis in Patients Referred for Treatment with Teriparatide
by: İnan Anaforoğlu, et al.
Published: (2013-12-01) -
Update on the safety and efficacy of teriparatide in the treatment of osteoporosis
by: Salvatore Minisola, et al.
Published: (2019-10-01) -
Role of teriparatide in treatment of glucocorticoid-induced osteoporosis
by: Arthur N Lau, et al.
Published: (2010-10-01) -
Impressive results of teriparatide treatment of postgastrectomy osteoporosis
by: Tatjana Bačun, et al.
Published: (2011-08-01)